Kamada extends emphysema drug deal with Baxter through 2017
September 29, 2014 at 08:07 AM EDT
JERUSALEM, Sept 29 (Reuters) - Israeli drugmaker Kamada said on Monday it extended an agreement with Baxter International to supply a drug to treat emphysema through 2017.
